DuPont de Nemours, Inc. (DD) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$1.1	$1.17	+6.4%	—	$1.8B	—
Q1 26	$1.45	$1.65	+13.8%	—	$1.7B	—
Q4 25	-$3.78	-$0.97	+74.3%	—	-$1.9B	—
Q3 25	$2.94	$3.27	+11.2%	—	$3.1B	—
Q2 25	$3.18	$3.36	+5.7%	—	$3.3B	—
Q1 25	$2.86	$3.09	+8.0%	—	$3.1B	—
Q4 24	$2.94	$3.39	+15.3%	—	$3.1B	—
Q3 24	$3.09	$3.54	+14.6%	—	$3.2B	—
Q2 24	$2.56	$2.91	+13.7%	—	$3.2B	—
Q1 24	$1.95	$2.37	+21.5%	—	$2.9B	—
Q4 23	$2.53	$2.61	+3.2%	—	$2.9B	—
Q3 23	$2.53	$2.76	+9.1%	—	$3.1B	—
Q2 23	$0.83	$0.85	+2.4%	—	$3.1B	—
Q1 23	$2.39	$2.52	+5.4%	—	$3B	—
Q4 22	$2.34	$2.67	+14.1%	—	$3.1B	—
Q3 22	$2.37	$2.46	+3.8%	—	$3.3B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	-$5.61	—	—	$6.8B	—
FY24	—	$1.68	—	—	$12.4B	—
FY23	—	$0.94	—	—	$12.1B	—
FY22	—	$11.6	—	—	$13B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$48.2B	$11.7B	$22.6B	$15.4B	$14.3B	$12.6B	$13B	$12.1B	$12.4B	$6.8B
YoY change	-1.27%	-75.8%	+93.6%	-31.7%	-7.11%	-12.4%	+3.59%	-7.29%	+2.64%	-44.7%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	48.2B	11.7B	22.6B	15.4B	14.3B	12.6B	13B	12.1B	12.4B	6.8B
Cost of revenue	37.7B	9.6B	15.3B	10B	9.5B	8B	8.4B	7.8B	7.9B	4.5B
Gross profit	10.5B	2.1B	7.3B	5.4B	4.8B	4.6B	4.6B	4.2B	4.5B	2.4B
Gross margin	21.8%	18.1%	32.3%	35%	33.7%	36.6%	35.5%	35.1%	36.4%	34.5%
Research & development	1.6B	657M	1.1B	689M	625M	557M	536M	508M	531M	193M
Selling, general & administrative	3B	1.6B	3B	2.1B	1.7B	1.6B	1.4B	1.4B	1.6B	1B
Operating expenses	4.5B	2.3B	4.1B	2.7B	2.3B	2.1B	2B	1.9B	2.1B	1.2B
Operating income	5.4B	-663M	2.1B	2B	1.8B	1.9B	2B	1.7B	1.8B	860M
Operating margin	11.2%	-5.68%	9.52%	12.7%	12.6%	15.1%	15.7%	14.2%	14.8%	12.6%
Non-operating income, net	-236M	-868M	-1.5B	-1.5B	-3.4B	57M	-160M	-963M	-344M	-445M
Pretax income	4.4B	-1.5B	600M	-126M	-2.2B	1.4B	1.4B	504M	1.2B	200M
Income tax	9M	-1.8B	195M	-2M	160M	237M	387M	-29M	414M	102M
Net income	4.4B	1.3B	4B	600M	-2.9B	6.5B	5.9B	462M	738M	-738M
Net margin	9.14%	11.1%	17.7%	3.89%	-20.4%	51.8%	45.5%	3.83%	5.96%	-10.8%
EBITDA	9B	3.7B	8.7B	5.3B	5.2B	3.1B	3.3B	3.1B	3.2B	1.6B
EPS	10.7	2.76	4.98	0.67	-4.01	2.17	11.6	0.94	1.68	-5.61
Diluted EPS	10.6	2.73	4.95	0.67	-4.01	2.16	11.6	0.94	1.68	-5.61

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	3.1B	2.9B	2.9B	3.2B	3.2B	3.1B	3.1B	3.3B	3.1B	-1.9B	1.7B	1.8B
Cost of revenue	2B	1.9B	1.9B	2B	2B	2B	1.9B	2B	1.9B	-816M	1.1B	1.2B
Gross profit	1.1B	1B	1B	1.2B	1.2B	1.1B	1.1B	1.2B	1.2B	-1.1B	602M	639M
Gross margin	36.1%	35.5%	34.6%	37.1%	37.4%	36.4%	37.4%	37.3%	38.9%	56.4%	35.8%	35.1%
Research & development	128M	128M	125M	134M	134M	138M	137M	142M	140M	-211M	47M	42M
Selling, general & administrative	360M	359M	384M	415M	387M	363M	369M	405M	387M	-108M	255M	269M
Operating expenses	488M	487M	509M	549M	521M	501M	506M	547M	527M	-319M	302M	311M
Operating income	461M	391M	355M	475M	524M	478M	494M	529M	547M	-652M	232M	260M
Operating margin	15.1%	13.5%	12.1%	15%	16.4%	15.5%	16.1%	16.2%	17.8%	34.8%	13.8%	14.3%
Non-operating income, net	15M	-929M	-12M	-101M	135M	-369M	-861M	-159M	-148M	-69M	-21M	20M
Pretax income	408M	-616M	267M	296M	586M	43M	-429M	306M	327M	-738M	181M	266M
Income tax	117M	-316M	84M	120M	106M	104M	119M	68M	19M	-89M	31M	75M
Net income	328M	-14M	197M	185M	462M	-106M	-582M	70M	-107M	-120M	164M	147M
Net margin	10.7%	-0.48%	6.72%	5.83%	14.5%	-3.43%	-19%	2.15%	-3.48%	6.41%	9.76%	8.08%
EBITDA	804M	726M	690M	823M	868M	815M	812M	1B	1B	-738M	406M	453M
EPS	0.71	-0.05	0.45	0.43	1.09	-0.28	-1.41	0.42	-0.87	-0.9	1.17	1.05
Diluted EPS	0.7	-0.05	0.45	0.42	1.08	-0.28	-1.41	0.42	-0.87	-0.9	1.17	1.05

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	37.8B	—	—	60.1B	65.7B	—	42.9B	43.4B	40.1B	—	17.7B
Enterprise value	52.5B	—	—	76B	78.7B	—	46.1B	48.8B	45.4B	—	19.3B
Shares outstanding	369.4M	526.6M	767M	746.3M	735.5M	542.7M	498.5M	449.9M	419.2M	139.2M	139.2M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	8.57	—	—	100.2	—	—	7.26	94	54.4	—	56.2
P/S	0.78	—	—	3.9	4.58	—	3.3	3.6	3.24	—	2.53
P/B	1.39	—	—	1.45	1.68	—	1.59	1.76	1.69	—	1.29
EV/EBITDA	5.84	—	—	14.2	15.2	—	13.8	15.9	14.2	—	12.2
EV/Sales	1.09	—	—	4.93	5.49	—	3.54	4.04	3.67	—	2.77
Earnings yield	11.7%	—	—	1%	—	—	13.8%	1.06%	1.84%	—	1.78%
FCF yield	-18.7%	—	—	-2.07%	4.31%	—	-0.17%	-1.06%	3.54%	—	10.4%
PEG	—	—	—	—	—	—	—	—	—	—	0.37

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	21.8%	18.1%	32.3%	35%	33.7%	36.6%	35.5%	35.1%	36.4%	34.5%	35.1%
Operating margin	11.2%	-5.68%	9.52%	12.7%	12.6%	15.1%	15.7%	14.2%	14.8%	12.6%	14.2%
Net margin	9.14%	11.1%	17.7%	3.89%	-20.4%	51.8%	45.5%	3.83%	5.96%	-10.8%	0.79%
ROE	16.2%	1.27%	4.17%	1.44%	-7.48%	24.1%	21.9%	1.87%	3.1%	-5.23%	1.79%
ROA	5.54%	0.67%	2.13%	0.87%	-4.12%	14.3%	14.3%	1.2%	2.01%	-3.42%	2.07%
ROIC	12.8%	-0.55%	1.45%	3.42%	3.47%	4.43%	4.99%	5.68%	4.1%	2.54%	0%
Return on tangible assets	11.9%	19.7%	4.47%	-2.49%	-16.8%	-932%	-199.8%	-7.09%	-10.2%	581.1%	-42.6%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	1.88	1.91	1.73	1.2	2.37	2.9	3.02	2.43	1.33	2.42	2.43
Quick ratio	1.29	1.26	1.67	0.68	2.18	2.48	2.4	1.73	0.88	1.91	1.82
Debt / equity	0.78	0.33	0.13	0.42	0.4	0.4	0.3	0.31	0.3	0.23	0.23
Debt / assets	0.27	0.18	0.07	0.25	0.22	0.24	0.2	0.2	0.2	0.15	0.15
Net debt / EBITDA	1.64	5.28	0.47	2.97	2.53	2.85	0.93	1.74	1.66	1.52	1.19
Interest coverage	6.14	—	11.9	0.81	-2.34	3.75	3.94	2.27	4.26	1.64	1.16
Effective tax rate	0.2%	0%	32.5%	0%	0%	16.4%	26.7%	0%	34.7%	51%	100%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	130.4	22.2	29.5	20.7	19.5	23.2	26.1	26.8	29.5	49.2	50.8
EPS (basic)	10.7	2.76	4.98	0.67	-4.01	2.17	11.6	0.94	1.68	-5.61	-5.61
EPS (diluted)	10.6	2.73	4.95	0.67	-4.01	2.16	11.6	0.94	1.68	-5.61	2.33
Book value per share	73.7	193.6	125	55.7	53.1	49.8	54.2	55	56.8	101.3	102
FCF per share	-19.1	-8.46	0.99	-1.67	3.85	-1.57	-0.15	-1.03	3.39	1.24	4.73
Cash per share	17.9	27.3	11.2	2.06	3.46	3.63	9.96	5.32	4.41	5.14	12.9
Capex per share	0.04	5.48	0.09	0.16	1.31	2.85	22	1.15	0.75	2.39	4.67

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	0.03%	24.7%	0.32%	0.77%	6.72%	12.3%	84.2%	4.28%	2.53%	4.86%	13.6%
Capex / operating cash flow	-0.47%	-129%	1.54%	-25.3%	61.2%	77.4%	850%	38.2%	14.8%	59.5%	61.4%
Payout ratio	55.9%	262.9%	87.3%	268.5%	-30.2%	9.67%	11%	140.9%	86%	-80.9%	130%
Dividend yield	6.52%	—	—	2.68%	1.34%	—	1.52%	1.5%	1.58%	—	1.83%

Yield

1.83%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.60

ex-dividend Aug 31, 2026

Payout ratio

130%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 31, 2026	$0.60
May 15, 2026	$0.20
Mar 2, 2026	$0.20

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$3.1B	$2.9B	$2.9B	$3.2B	$3.2B	$3.1B	$3.1B	$3.3B	$3.1B	-$1.9B	$1.7B	$1.8B
YoY change	-7.81%	-6.64%	-2.88%	+2.49%	+4.38%	+6.69%	+4.61%	+2.71%	-3.76%	-160.5%	-45.2%	-44.2%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	6.6B	14.4B	8.6B	1.5B	2.5B	2B	5B	2.4B	1.9B	715M
Receivables	4.7B	11.3B	2.9B	3B	1.9B	1.6B	1.6B	1.5B	1.5B	910M
Inventory	7.4B	17B	4.1B	4.3B	2.4B	2.1B	2.3B	2.1B	2.1B	1.2B
Total current assets	23.7B	49.9B	126.7B	10B	29B	14.3B	11.3B	7.5B	6.4B	5.6B
Property, plant & equipment	17.6B	27.6B	12.8B	7.3B	4.8B	3.8B	3.8B	3.8B	3.5B	1.9B
Goodwill & intangibles	42.6B	185.6B	98.3B	93.5B	53.5B	46.4B	44.3B	45.1B	43.9B	21.7B
Total assets	79.5B	192.2B	187.9B	69.3B	70.9B	45.7B	41.4B	38.6B	36.6B	21.6B
Accounts payable	4.5B	9.1B	2.6B	2.9B	2.2B	2.1B	2.1B	1.7B	1.7B	995M
Short-term debt	907M	4B	15M	3.8B	1M	150M	300M	—	1.8B	60M
Total current liabilities	12.6B	26.1B	73.3B	8.3B	12.2B	4.9B	3.7B	3.1B	4.8B	2.3B
Long-term debt	20.5B	30.1B	12.6B	13.6B	15.6B	10.6B	7.8B	7.7B	5.3B	3.1B
Total liabilities	52.3B	90.2B	92B	27.8B	31.8B	18.7B	14.3B	13.8B	12.8B	7.5B
Shareholders' equity	27.2B	101.9B	95.9B	41.6B	39.1B	27.1B	27B	24.7B	23.8B	14.1B
Total debt	21.4B	34.1B	12.6B	17.4B	15.6B	10.8B	8.1B	7.7B	7.2B	3.2B
Net debt	14.8B	20.6B	4.1B	15.9B	13.1B	8.8B	4.4B	5.3B	5.3B	2.5B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	1.3B	2.4B	1.9B	1.5B	1.6B	1.9B	1.8B	1.8B	2B	715M	710M	1.7B
Receivables	1.6B	1.5B	1.6B	2.3B	2.4B	1.5B	2.3B	2.5B	2.4B	910M	1.7B	1.8B
Inventory	2.3B	2.1B	2.2B	2.2B	2.2B	2.1B	2.2B	2.3B	1.8B	1.2B	1.2B	1.2B
Total current assets	7.9B	7.5B	7.1B	6.2B	6.4B	6.4B	6.5B	6.8B	10B	5.6B	5.6B	4.9B
Property, plant & equipment	-4.7B	3.8B	-4.9B	-5B	-5.2B	3.5B	-5.4B	-5.5B	-4.9B	1.9B	-3.6B	-3.7B
Goodwill & intangibles	46.6B	45.1B	44.5B	44.1B	44.9B	43.9B	42.4B	42.8B	41.5B	21.7B	21.4B	21.3B
Total assets	39.1B	38.6B	37.7B	36.6B	37.5B	36.6B	36B	36.6B	38B	21.6B	21.4B	21.1B
Accounts payable	1.7B	1.7B	1.6B	1.7B	1.7B	1.7B	1.7B	1.7B	1.7B	995M	882M	978M
Short-term debt	475M	—	—	—	—	1.8B	1.8B	1.8B	1.9B	60M	40M	—
Total current liabilities	3.7B	3.1B	3B	2.8B	2.8B	4.8B	4.6B	4.9B	5B	2.3B	2.1B	2B
Long-term debt	7.6B	7.7B	7.7B	7.1B	7.1B	5.3B	5.3B	5.3B	7B	3.1B	3.1B	3.1B
Total liabilities	14.5B	13.8B	13.7B	12.8B	12.8B	12.8B	12.7B	13B	14.7B	7.5B	7.2B	7.2B
Shareholders' equity	24.6B	24.7B	24B	23.8B	24.7B	23.8B	23.3B	23.5B	23.3B	14.1B	14.2B	13.9B
Total debt	8.1B	7.7B	7.7B	7.1B	7.1B	7.2B	7.2B	7.2B	8.9B	3.2B	3.2B	3.1B
Net debt	6.8B	5.3B	5.8B	5.6B	5.5B	5.3B	5.4B	5.3B	6.9B	2.5B	2.5B	1.4B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	4.4B	1.3B	4B	600M	-2.9B	1.2B	1.1B	533M	778M	98M
Depreciation & amortization	2.9B	4B	5.9B	3.2B	3.1B	1.1B	1.1B	1.1B	1.2B	647M
Stock-based compensation	—	—	—	—	—	—	—	—	77M	38M
Change in working capital	-8.4B	-7.5B	-5.4B	-4B	1.2B	-230M	-855M	-155M	222M	-313M
Operating cash flow	-3.4B	-2.2B	4.7B	-471M	1.6B	2B	1.3B	1.4B	2.1B	560M
Capital expenditure	-16M	2.9B	72M	119M	963M	-1.5B	11B	-517M	-313M	-333M
Investing cash flow	236M	8.3B	696M	179M	992M	-1.5B	9.7B	791M	-270M	-319M
Dividends paid	-2.5B	-3.4B	-3.5B	-1.6B	-882M	-630M	-652M	-651M	-635M	-597M
Share repurchases	-916M	-1B	-4.4B	-2.3B	-232M	-2.1B	-4.4B	-2B	-500M	-500M
Financing cash flow	-4B	-6.6B	-1.9B	-11.6B	3.2B	-6.3B	-7.8B	-3B	-1.8B	-1.8B
Net change in cash	-7.2B	-465M	3.5B	-11.8B	5.8B	-5.8B	3.2B	-843M	0	-1.5B
Free cash flow	-7.1B	-4.5B	760M	-1.2B	2.8B	-853M	-74M	-462M	1.4B	172M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	291M	-300M	183M	176M	480M	-61M	-548M	-390M	643M	-649M	150M	191M
Depreciation & amortization	294M	294M	291M	298M	306M	299M	293M	429M	446M	-125M	155M	154M
Stock-based compensation	—	—	—	—	—	—	12M	24M	21M	-5M	13M	14M
Change in working capital	158M	10M	-1M	4M	129M	90M	-159M	-215M	52M	-77M	-104M	15M
Operating cash flow	724M	-188M	500M	472M	977M	176M	-321M	412M	1.1B	-700M	153M	479M
Capital expenditure	-1.7B	1.2B	5M	-8M	-324M	14M	0	-243M	-311M	150M	-102M	-76M
Investing cash flow	-1.8B	1.2B	5M	-8M	-311M	37M	2M	-238M	-314M	160M	-102M	-76M
Dividends paid	-165M	-156M	-159M	-158M	-159M	-159M	-172M	-171M	-172M	-82M	-82M	-81M
Share repurchases	-2B	0	-500M	0	0	0	0	0	0	-500M	—	—
Financing cash flow	-2B	-630M	-691M	-153M	-140M	-176M	-206M	-201M	-222M	-1.2B	-44M	-106M
Net change in cash	-3B	418M	-186M	311M	526M	37M	-525M	-27M	573M	-1.8B	7M	297M
Free cash flow	-1.1B	228M	286M	417M	301M	409M	133M	169M	737M	-544M	51M	403M

Date	Ratio
Jun 24, 2026	1:3
Nov 3, 2025	239:100
Jun 3, 2019	4725:10000
Apr 2, 2019	1487:1000
Jun 19, 2000	3:1
Nov 21, 1989	3:2
Jun 8, 1976	2:1

DuPont de Nemours, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history